Trial document
This trial has been registered retrospectively.
DRKS00022110
Trial Description
Title
Patients with chronic pain prefer maintenance of pain treatment despite COVID-19 pandemic restrictions
Trial Acronym
[---]*
URL of the Trial
Brief Summary in Lay Language
In this prospective study, patients suffering from chronic pain treated at a large German interdisciplinary pain center were studied over a period of 2 months at the beginning of the pandemic. Data from patient charts and questionnaires were evaluated. Patients were asked about postponements or cancellations of pain therapy, the possible effect on pain levels, depression, anxiety and stress and the impact of intensified hygiene measures. Results were compared to those from standardized and validated questionnaires from the same patients (German version of the depression, anxiety and stress scale = DASS) at time of the first contact in the pain clinic.
Brief Summary in Scientific Language
The aim of this prospective study is to clarify whether chronic pain patients are impaired in treatment by the hygiene measures caused by the pandemic.
Do you plan to share individual participant data with other researchers?
Yes
Description IPD sharing plan:
The anonymised study data will be published as supplementary data.
Organizational Data
- DRKS00022110
- 2020/12/21
- [---]*
- yes
- Approved
- 353/20, Ethik-Kommission der Albert-Ludwigs-Universität Freiburg
Secondary IDs
- U1111-1262-4221
Health Condition or Problem studied
- F45.41 - [generalization F45.4: Persistent somatoform pain disorder]
Interventions/Observational Groups
- Patients are interviewed using a questionnaire and telephone interview.
Characteristics
- Non-interventional
- Observational study
- Other
- Open (masking not used)
- [---]*
- Other
- Supportive care
- Other
- [---]*
- N/A
Primary Outcome
Survey by means of a questionnaire and telephone interview
Secondary Outcome
There is none
Countries of Recruitment
- Germany
Locations of Recruitment
- University Medical Center
Recruitment
- Actual
- 2020/06/15
- 400
- Monocenter trial
- National
Inclusion Criteria
- Both, male and female
- 18 Years
- 99 Years
Additional Inclusion Criteria
patients with chronic pain and treatment in the pain clinic during the COVID-19 pandemic
Exclusion Criteria
younger than 18 years, inadequate German language skills
Addresses
-
start of 1:1-Block address primary-sponsor
- Universitätsklinikum Freiburg, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg
- Breisacherstrasse 117
- 79106 Freiburg
- Germany
end of 1:1-Block address primary-sponsorstart of 1:1-Block address contact primary-sponsor- [---]*
- [---]*
- [---]*
- [---]*
end of 1:1-Block address contact primary-sponsor -
start of 1:1-Block address scientific-contact
- Interdisziplinäres SchmerzzentrumUniversitätsklinikum Freiburg, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg
- Ms. Dr. med., MSc. Barbara Kleinmann
- Breisacherstrasse 117
- 79106 Freiburg
- Germany
end of 1:1-Block address scientific-contactstart of 1:1-Block address contact scientific-contact- 0761 270 50200
- 0761 270 50130
- barbara.kleinmann at uniklinik-freiburg.de
- http:// http://www.uniklinik-freiburg.de/schmerzzentrum.html
end of 1:1-Block address contact scientific-contact -
start of 1:1-Block address public-contact
- Interdisziplinäres SchmerzzentrumUniversitätsklinikum FreiburgMedizinische Fakultät
- Ms. Dr. Barbara Kleinmann
- Breisacherstrasse 117
- 79106 Freiburg
- Germany
end of 1:1-Block address public-contactstart of 1:1-Block address contact public-contact- 0761 270 50020
- 0761 270 50130
- barbara.kleinmann at uniklinik-freiburg.de
- http://www.uniklinik-freiburg.de/schmerzzentrum.html
end of 1:1-Block address contact public-contact
Sources of Monetary or Material Support
-
start of 1:1-Block address materialSupport
- Universitätsklinikum Freiburg, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg
- Breisacherstrasse 117
- 79106 Freiburg
- Germany
end of 1:1-Block address materialSupportstart of 1:1-Block address contact materialSupport- [---]*
- [---]*
- [---]*
- [---]*
end of 1:1-Block address contact materialSupport
Status
- Recruiting complete, follow-up complete
- 2020/10/30
Trial Publications, Results and other Documents
- [---]*